• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回顾性分析与浅表取出相比,与深部避孕植入物取出相关的因素。

A retrospective analysis of factors associated with deep contraceptive implant removals compared to superficial removals.

机构信息

Department of Obstetrics and Gynecology, Division of Family Planning, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Department of Obstetrics and Gynecology, Division of Family Planning, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

出版信息

Contraception. 2024 Sep;137:110486. doi: 10.1016/j.contraception.2024.110486. Epub 2024 May 14.

DOI:10.1016/j.contraception.2024.110486
PMID:38754757
Abstract

OBJECTIVE

To identify factors associated with the need for a deep etonogestrel contraceptive implant removal as compared to superficial removal.

STUDY DESIGN

We conducted a retrospective cohort study of patients undergoing contraceptive implant removal from January 2014 to January 2023. We extracted key patient characteristics from electronic health record review and compared patients requiring deep removal versus routine superficial removal using Chi-squared, Fischer's exact, and Mann-Whitney U test. A multivariate logistic regression identified variables associated with increased odds of requiring a deep implant removal.

RESULTS

The deep and superficial removal groups included 162 and 585 patients, respectively. Deep removal was associated with younger age at removal (median 25.0 vs 26.0 years, p = 0.005), lower body mass index (BMI) at insertion (median 23.2 kg/m vs 26.6 kg/m, p = 0.024), BMI≥ 40 kg/m at removal (15.2% vs 7.0%, p = 0.007), weight gain during implant use (median 6.6 vs 1.8 kg, p ≤ 0.001), longer duration of use (median 36.0 vs 27.5 months, p < 0.001), implant exchange (37.3% vs 17.4%, p < 0.001), and insertion by non-physician (43.3% vs 19.3%, p < 0.001) or non-obstetrican and gynecologist (31.4% vs 11.8%, p < 0.001). Lower BMI at insertion (aOR 0.92, [95% CI 0.87-0.98]), weight gain during use (aOR 1.06 [95% CI 1.02-1.10]), and longer duration of use (aOR 1.05 [95% CI 1.02-1.07]) remained significantly associated with deep removal in regression analysis.

CONCLUSION(S): We identified lower BMI at insertion, weight gain during use, and longer duration of use as independent factors associated with increased likelihood of needing a deep contraceptive implant removal.

IMPLICATIONS

Clinicians should utilize proper technique when inserting contraceptive implants, especially in patients at risk for deep insertion, and ensure immediate referral to Centers of Experience for patients with non-palpable implants.

摘要

目的

确定与深层依托孕烯皮下埋植剂取出相比,浅层取出所需的相关因素。

研究设计

我们对 2014 年 1 月至 2023 年 1 月期间接受皮下埋植剂取出的患者进行了回顾性队列研究。我们从电子健康记录回顾中提取了关键患者特征,并使用卡方检验、Fisher 确切检验和曼-惠特尼 U 检验比较了需要深层取出和常规浅层取出的患者。多变量逻辑回归确定了与增加深层植入物取出几率相关的变量。

结果

深层和浅层取出组分别包括 162 例和 585 例患者。深层取出与取出时年龄较小(中位数 25.0 岁 vs. 26.0 岁,p=0.005)、插入时体重指数(BMI)较低(中位数 23.2kg/m vs. 26.6kg/m,p=0.024)、取出时 BMI≥40kg/m(15.2% vs. 7.0%,p=0.007)、使用植入物期间体重增加(中位数 6.6kg vs. 1.8kg,p≤0.001)、使用时间较长(中位数 36.0 个月 vs. 27.5 个月,p<0.001)、植入物更换(37.3% vs. 17.4%,p<0.001)、非医生(43.3% vs. 19.3%,p<0.001)或非妇产科医生(31.4% vs. 11.8%,p<0.001)插入有关。插入时 BMI 较低(OR 0.92,95%CI 0.87-0.98)、使用期间体重增加(OR 1.06,95%CI 1.02-1.10)和使用时间较长(OR 1.05,95%CI 1.02-1.07)在回归分析中仍与深层取出显著相关。

结论

我们发现,插入时 BMI 较低、使用期间体重增加和使用时间较长是与需要深层避孕植入物取出相关的独立因素。

意义

临床医生在插入避孕植入物时应采用适当的技术,特别是在有深层插入风险的患者中,并确保对不可触及植入物的患者立即转介至经验中心。

相似文献

1
A retrospective analysis of factors associated with deep contraceptive implant removals compared to superficial removals.回顾性分析与浅表取出相比,与深部避孕植入物取出相关的因素。
Contraception. 2024 Sep;137:110486. doi: 10.1016/j.contraception.2024.110486. Epub 2024 May 14.
2
The association between BMI and continuity of etonogestrel (ENG)-releasing implant.体质指数(BMI)与依托孕烯(ENG)释放埋植剂续用的关系。
Int J Gynaecol Obstet. 2024 Oct;167(1):254-258. doi: 10.1002/ijgo.15590. Epub 2024 May 7.
3
Factors associated with removal difficulties of etonogestrel-containing contraceptive implants (Nexplanon).与含依托孕烯避孕植入剂(依伴依)取出困难相关的因素。
Eur J Obstet Gynecol Reprod Biol. 2018 May;224:81-84. doi: 10.1016/j.ejogrb.2018.03.019. Epub 2018 Mar 13.
4
The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.产后即刻与产后延迟及间隔放置依托孕烯避孕植入剂对因出血导致的取出率的影响。
Contraception. 2014 Sep;90(3):253-8. doi: 10.1016/j.contraception.2014.05.010. Epub 2014 May 24.
5
Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.与医疗补助支付改革后延迟或间隔植入避孕植入物相比,选择产后住院的女性在6个月和12个月时有记录的取出率。
Contraception. 2017 Jan;95(1):71-76. doi: 10.1016/j.contraception.2016.07.004. Epub 2016 Jul 8.
6
Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA).关于依伴侬®(Nexplanon®)手术相关事件的真实世界数据:依伴侬观察性风险评估研究(NORA)的最终结果。
Contraception. 2019 Jul;100(1):31-36. doi: 10.1016/j.contraception.2019.03.052. Epub 2019 Apr 10.
7
Nonpalpable implant removals at centre of experience in France: a cohort study.法国的一项队列研究关注不可触及植入物的取出:
Eur J Contracept Reprod Health Care. 2024 Aug;29(4):163-170. doi: 10.1080/13625187.2024.2349039. Epub 2024 May 30.
8
Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.药物流产时立即与延迟植入依托孕烯释放植入剂的随机对照等效性试验
Hum Reprod. 2016 Nov;31(11):2484-2490. doi: 10.1093/humrep/dew238. Epub 2016 Sep 22.
9
A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.一项为期3年的多中心随机对照试验,比较依托孕烯和左炔诺孕酮释放型避孕植入剂,并设有非随机匹配的铜宫内节育器对照组。
Hum Reprod. 2015 Nov;30(11):2527-38. doi: 10.1093/humrep/dev221. Epub 2015 Sep 25.
10
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.依托孕烯释放皮下避孕植入剂长达5年的延长使用:与左炔诺孕酮释放皮下植入剂的比较。
Hum Reprod. 2016 Nov;31(11):2491-2498. doi: 10.1093/humrep/dew222. Epub 2016 Sep 26.

引用本文的文献

1
Social Determinants of Health and Patient-Reported Difficult Discontinuation of Long-Acting Reversible Contraception.健康的社会决定因素与患者报告的长效可逆避孕法停药困难
J Womens Health (Larchmt). 2024 Dec;33(12):1635-1644. doi: 10.1089/jwh.2023.0857. Epub 2024 Jul 22.